Piramal Pharma Limited — Important, 04-07-2025: General Updates
04-07-2025 | 05:15 pm
04-07-2025 | 05:15 pm
Piramal Pharma's wholly owned subsidiary, Piramal Critical Care Inc., has received USD 2.42 million as settlement from Astral SteriTech under an approved resolution plan, concluding its insolvency claim. This marks the closure of the legal dispute, improving cash flow and reducing contingent liabilities for Piramal Pharma.
No comments yet. Be the first to comment!
